Letters Drug eluting stents

What fuels public policy?

BMJ 2007; 334 doi: http://dx.doi.org/10.1136/bmj.39150.648762.BE (Published 22 March 2007) Cite this as: BMJ 2007;334:599

This article has a correction. Please see:

  1. Mark H Wilson, director of medical ethics health ([email protected])
  1. Health Research Associates, Ottawa, Canada K2B 6J4

    Around 60-75% of the millions of drug eluting stents inserted globally are not licensed.1 What has fuelled the high unlicensed use of a device associated with thrombosis? This question was not dealt with by the Food and Drug Administration panel or recent articles on such stents.2 …

    View Full Text

    Sign in

    Log in through your institution

    Free trial

    Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
    Sign up for a free trial

    Subscribe